CIBC World Market
ALDX icon

CIBC World Market’s Aldeyra Therapeutics ALDX Stock Holding History

CIBC World Market’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,000
Closed -$35K – 1289
2023
Q4 		$35K Hold
10,000
– – ﹤0.01% 1224
2023
Q3 		$67K Hold
10,000
– – ﹤0.01% 1189
2023
Q2 		$84K Hold
10,000
– – ﹤0.01% 1169
2023
Q1 		$99K Hold
10,000
– – ﹤0.01% 1190
2022
Q4 		$70K Hold
10,000
– – ﹤0.01% 1210
2022
Q3 		$53K Hold
10,000
– – ﹤0.01% 1199
2022
Q2 		$40K Hold
10,000
– – ﹤0.01% 1230
2022
Q1 		$44K Hold
10,000
– – ﹤0.01% 1276
2021
Q4 		$40K Hold
10,000
– – ﹤0.01% 1302
2021
Q3 		$88K Hold
10,000
– – ﹤0.01% 1297
2021
Q2 		$113K Sell
10,000
-5,000
-33% -$60.1K ﹤0.01% 1297
2021
Q1 		$178K Hold
15,000
– – ﹤0.01% 1230
2020
Q4 		$103K Hold
15,000
– – ﹤0.01% 1229
2020
Q3 		$111K Hold
15,000
– – ﹤0.01% 1062
2020
Q2 		$63K Buy
+15,000
New +$54.8K ﹤0.01% 1046

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIBC World Market's ALDX Position: Q1 2024 in Review

CIBC World Market sold out of Aldeyra Therapeutics (ALDX) in Q1 2024, closing a stake of 10,000 shares — an estimated $35K sold.

CIBC World Market first reported a position in ALDX in Q2 2020 and held it in 15 quarters. The position peaked at $178K in Q1 2021. 102 funds tracked by Wall St. Rank hold ALDX as of Q1 2024.

  • CIBC World Market reported no remaining Aldeyra Therapeutics position as of Q1 2024 after selling out during the quarter.
  • CIBC World Market sold 10,000 Aldeyra Therapeutics shares in Q1 2024, an estimated $35K.
  • CIBC World Market first reported a position in Aldeyra Therapeutics in Q2 2020 and held it in 15 quarters.
  • CIBC World Market's Aldeyra Therapeutics position peaked at $178K in Q1 2021.
  • 102 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2024.

Based on CIBC World Market's 13F filing for Q1 2024, filed 13 May 2024.